全文获取类型
收费全文 | 39099篇 |
免费 | 3524篇 |
国内免费 | 21篇 |
专业分类
42644篇 |
出版年
2023年 | 237篇 |
2022年 | 497篇 |
2021年 | 1062篇 |
2020年 | 611篇 |
2019年 | 776篇 |
2018年 | 918篇 |
2017年 | 772篇 |
2016年 | 1199篇 |
2015年 | 1991篇 |
2014年 | 2214篇 |
2013年 | 2356篇 |
2012年 | 3330篇 |
2011年 | 3033篇 |
2010年 | 1947篇 |
2009年 | 1674篇 |
2008年 | 2410篇 |
2007年 | 2359篇 |
2006年 | 2132篇 |
2005年 | 2013篇 |
2004年 | 1853篇 |
2003年 | 1740篇 |
2002年 | 1620篇 |
2001年 | 345篇 |
2000年 | 247篇 |
1999年 | 350篇 |
1998年 | 413篇 |
1997年 | 276篇 |
1996年 | 247篇 |
1995年 | 209篇 |
1994年 | 218篇 |
1993年 | 221篇 |
1992年 | 221篇 |
1991年 | 208篇 |
1990年 | 194篇 |
1989年 | 170篇 |
1988年 | 180篇 |
1987年 | 170篇 |
1986年 | 136篇 |
1985年 | 138篇 |
1984年 | 169篇 |
1983年 | 131篇 |
1982年 | 163篇 |
1981年 | 148篇 |
1980年 | 138篇 |
1979年 | 108篇 |
1978年 | 114篇 |
1977年 | 101篇 |
1976年 | 88篇 |
1974年 | 74篇 |
1973年 | 89篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
121.
Interaction of lectins with a detergent-solubilized ATPase from eel electric organ was studied. Concanavalin A, which binds to alpha-mannosides, altered the rate of enzyme migration in agar and inhibited the formation of an antigen-antibody precipitate: other lectins had no such effects. Concanavalin A similar amounts partially inhibited (Na+ + K+)-ATPase; this inhibition was reversible by alpha-methylglucoside. There was no corresponding effect of concanavalin A on the potassium p-nitrophenylphosphatase. Concanavalin A also did not interfere with ouabain binding. Thus, concanavalin A binds to an antigenic region also involved in Na+ and/or ATP binding, but does not interact with a K+ site. 相似文献
122.
123.
Daniel Melin 《Phytochemistry》1975,14(11):2363-2369
The flavonoid content of the vegetative stems of Periploca graeca include derivatives of flavonols (quercetin and kaempferol), anthocyanidins ( 相似文献
124.
125.
Laura
iburc Marius Bembea Dana Carmen Zaha Alexandru Daniel Jurca Cosmin Mihai Vesa Ioana Adela Raiu Claudia Maria Jurca 《Current issues in molecular biology》2022,44(5):1851
IL-17 inhibitors (IL-17i) are medicines used to treat dermatological and rheumatic diseases They belong to a class of medicines called biological disease-modifying anti-rheumatic drugs (bDMARDs). This class of drugs has had a major impact on the therapy of autoimmune diseases, being much safer and more effective than treatment with small molecules. At the same time, they have highly beneficial effects on skin and joint changes, and their efficacy has been extensively monitored and demonstrated in numerous clinical trials. More and more such drugs are still being discovered today to ensure the best possible treatment of these patients, but more frequently and relatively constantly three agents are used. Two of them (Secukinumab and Ixekizumab) inhibit IL-17A directly, and the third, Brodamulab, inhibits the IL-17A receptor. Although they are extremely effective in the treatment of these diseases, sometimes their administration has been associated with paradoxical effects, i.e., there is an exacerbation of the inflammatory process. Tough, clinical trials of IL-17i have described cases of exacerbation or even onset of inflammatory bowel disease (IBD), such as Crohn’s disease and ulcerative colitis, after administration of these drugs in patients previously diagnosed with psoriasis (PS), psoriatic arthritis (PsA), or ankylosing spondylitis (AS). The pathophysiological mechanism of action is not well understood at present. One explanation would be that this hyperreactive inflammatory process would be triggered by Interferon 1 derived from dendritic plasma cells. Even though there are many reports in the recent literature about the role of IL17i in the onset of IBD, conclusions of studies do not converge. Some of them show an increased incidence of IBD in patients treated with IL17i, while some others affirm their safety of them. In the near future we will surely have more data emerging from ongoing meta-analyses regarding safety of use IL17i in patients who are at risk of developing IBD. Clinical and paraclinical evaluation (inflammatory intestinal markers) are carefully advised before recommending treatment with IL-17i and after initiation of treatment, and prospective surveillance by clinical and biomarkers of patients treated with IL-17i is absolutely essential to capture the onset of IBD. 相似文献
126.
Prabhodh S. Abbineni Joseph S. Briguglio Edwin R. Chapman Ronald W. Holz Daniel Axelrod 《Molecular biology of the cell》2022,33(6)
Granule-plasma membrane docking and fusion can only occur when proteins that enable these reactions are present at the granule-plasma membrane contact. Thus, the mobility of granule membrane proteins may influence docking and membrane fusion. We measured the mobility of vesicle associated membrane protein 2 (VAMP2), synaptotagmin 1 (Syt1), and synaptotagmin 7 (Syt7) in chromaffin granule membranes in living chromaffin cells. We used a method that is not limited by standard optical resolution. A bright flash of strongly decaying evanescent field produced by total internal reflection was used to photobleach GFP-labeled proteins in the granule membrane. Fluorescence recovery occurs as unbleached protein in the granule membrane distal from the glass interface diffuses into the more bleached proximal regions, enabling the measurement of diffusion coefficients. We found that VAMP2-EGFP and Syt7-EGFP are mobile with a diffusion coefficient of ∼3 × 10−10 cm2/s. Syt1-EGFP mobility was below the detection limit. Utilizing these diffusion parameters, we estimated the time required for these proteins to arrive at docking and nascent fusion sites to be many tens of milliseconds. Our analyses raise the possibility that the diffusion characteristics of VAMP2 and Syt proteins could be a factor that influences the rate of exocytosis. 相似文献
127.
128.
129.
Hadi Shahrabadi Amir Hossein Haghighi Roya Askari Majid Asadi-Shekaari Daniel Costa Souza Paulo Gentil 《Current issues in molecular biology》2022,44(7):3030
Chronic methamphetamine use increases apoptosis, leading to heart failure and sudden cardiac death. Previous studies have shown the importance of high-intensity interval training (HIIT) in reducing indices of cardiac tissue apoptosis in different patients, but in the field of sports science, the molecular mechanisms of apoptosis in methamphetamine-dependent rats are still unclear. The present article aimed to investigate the changes in cardiac apoptosis markers in methamphetamine-dependent rats in response to HIIT. Left ventricular tissue was used to evaluate caspase-3, melusin, FAK, and IQGAP1 gene expression. Rats were divided into four groups: sham, methamphetamine (METH), METH-control, and METH-HIIT. METH was injected for 21 days and then the METH-HIIT group performed HIIT for 8 weeks at 5 sessions per week. The METH groups showed increased caspase-3 gene expression and decreased melusin, FAK, and IQGAP1 when compared to the sham group. METH-HIIT showed decreased caspase-3 and increased melusin and FAK gene expression compared with the METH and METH-control groups. The IQGAP1 gene was higher in METH-HIIT when compared with METH, while no difference was observed between METH-HIIT and METH-control. Twenty-one days of METH exposure increased apoptosis markers in rat cardiac tissue; however, HIIT might have a protective effect, as shown by the apoptosis markers. 相似文献
130.
Jamie L. Dombach Joaquin LJ Quintana Samual C. Allgood Toni A. Nagy Daniel L. Gustafson Corrella S. Detweiler 《PLoS pathogens》2022,18(6)
As pathogenic bacteria become increasingly resistant to antibiotics, antimicrobials with mechanisms of action distinct from current clinical antibiotics are needed. Gram-negative bacteria pose a particular problem because they defend themselves against chemicals with a minimally permeable outer membrane and with efflux pumps. During infection, innate immune defense molecules increase bacterial vulnerability to chemicals by permeabilizing the outer membrane and occupying efflux pumps. Therefore, screens for compounds that reduce bacterial colonization of mammalian cells have the potential to reveal unexplored therapeutic avenues. Here we describe a new small molecule, D66, that prevents the survival of a human Gram-negative pathogen in macrophages. D66 inhibits bacterial growth under conditions wherein the bacterial outer membrane or efflux pumps are compromised, but not in standard microbiological media. The compound disrupts voltage across the bacterial inner membrane at concentrations that do not permeabilize the inner membrane or lyse cells. Selection for bacterial clones resistant to D66 activity suggested that outer membrane integrity and efflux are the two major bacterial defense mechanisms against this compound. Treatment of mammalian cells with D66 does not permeabilize the mammalian cell membrane but does cause stress, as revealed by hyperpolarization of mitochondrial membranes. Nevertheless, the compound is tolerated in mice and reduces bacterial tissue load. These data suggest that the inner membrane could be a viable target for anti-Gram-negative antimicrobials, and that disruption of bacterial membrane voltage without lysis is sufficient to enable clearance from the host. 相似文献